Literature DB >> 2943049

Platelet activation during exercise induced asthma: effect of prophylaxis with cromoglycate and salbutamol.

C E Johnson, P W Belfield, S Davis, N J Cooke, A Spencer, J A Davies.   

Abstract

Peak expiratory flow (PEF) and plasma concentrations of platelet factor 4 and beta thromboglobulin were measured before and after exercise in nine asthmatic patients and 12 non-asthmatic volunteers. Exercise was preceded by administration in random order of either placebo, salbutamol 200 micrograms, or sodium cromoglycate 2 mg from a pressurised inhaler. In control subjects there were minimal changes in PEF and plasma concentrations of platelet factor 4 and beta thromboglobulin. In the asthmatic patients the typical changes in PEF were seen on exercise; plasma concentrations of platelet factor 4 and beta thromboglobulin rose significantly in parallel, the rise preceding the fall in PEF. The changes in peak flow and platelet activation induced by exercise were attenuated by prior administration of salbutamol or cromoglycate. These results indicate that exercise induced asthma is associated with a rise in platelet release products similar to that observed in antigen induced asthma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943049      PMCID: PMC460312          DOI: 10.1136/thx.41.4.290

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma.

Authors:  G S Basran; J Morley; W Paul; M Turner-Warwick
Journal:  Lancet       Date:  1982-04-24       Impact factor: 79.321

2.  Measurement of plasma histamine in asthma.

Authors:  P W Ind; P J Barnes; M J Brown; R Causon; C T Dollery
Journal:  Clin Allergy       Date:  1983-01

3.  Platelet activation and allergic asthma.

Authors:  P Gresele; T Todisco; F Merante; G G Nenci
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

4.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

5.  Platelet activation during antigen-induced airway reactions in asthmatic subjects.

Authors:  K A Knauer; L M Lichtenstein; N F Adkinson; J E Fish
Journal:  N Engl J Med       Date:  1981-06-04       Impact factor: 91.245

6.  Evaluation of role played by mediators of immediate hypersensitivity in exercise-induced asthma.

Authors:  E C Deal; S I Wasserman; N A Soter; R H Ingram; E R McFadden
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

7.  The link between exercise, respiratory heat exchange, and the mast cell in bronchial asthma.

Authors:  T H Lee; B K Assoufi; A B Kay
Journal:  Lancet       Date:  1983-03-05       Impact factor: 79.321

8.  Neutrophil chemotactic activity in antigen-induced late asthmatic reactions.

Authors:  L Nagy; T H Lee; A B Kay
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

9.  A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics.

Authors:  M J Brown; P W Ind; R Causon; T H Lee
Journal:  J Allergy Clin Immunol       Date:  1982-01       Impact factor: 10.793

10.  Histamine, neutrophil chemotactic factor and circulating basophil levels following exercise in asthmatic and control subjects.

Authors:  D J Morgan; M J Phillips; I Moodley; E V Elliott; R J Davies
Journal:  Clin Allergy       Date:  1982-10
View more
  9 in total

1.  Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma.

Authors:  Mats W Johansson; Shih-Tsung Han; Kristin A Gunderson; William W Busse; Nizar N Jarjour; Deane F Mosher
Journal:  Am J Respir Crit Care Med       Date:  2012-01-06       Impact factor: 21.405

2.  Effects of a PAF-antagonist (BN 52063) on bronchoconstriction and platelet activation during exercise induced asthma.

Authors:  J H Wilkens; H Wilkens; J Uffmann; J Bövers; H Fabel; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

3.  The abnormal in vitro response to aspirin of platelets from aspirin-sensitive asthmatics is inhibited after inhalation of nedocromil sodium but not of sodium cromoglycate.

Authors:  C H Marquette; M Joseph; A B Tonnel; H Vorng; P Lassalle; A Tsicopoulos; A Capron
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

Review 4.  Platelet activating factor and asthma.

Authors:  J Morley
Journal:  Agents Actions       Date:  1986-10

Review 5.  Platelets and Their Interactions with Other Immune Cells.

Authors:  Fong W Lam; K Vinod Vijayan; Rolando E Rumbaut
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

Review 6.  Platelets in patients with aspirin-exacerbated respiratory disease.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2015-06       Impact factor: 10.793

7.  The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.

Authors:  M L Taylor; G A Stewart; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

8.  Platelet activation in nocturnal asthma.

Authors:  J F Morrison; S B Pearson; H G Dean; I R Craig; P N Bramley
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

Review 9.  Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.

Authors:  C H Spooner; G R Spooner; B H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.